Disappearing gastrointestinal microbiota in epidemic obesity.
流行性肥胖症中胃肠道微生物群的消失。
基本信息
- 批准号:8780962
- 负责人:
- 金额:$ 121.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-01-01 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:AgeAntibiotic TherapyAntibioticsBacteriaBirthChildCommunitiesDeveloped CountriesDevelopmentDevelopmental ProcessDoseEndoscopyEnrollmentEnsureEpidemicEpitheliumFecesGastrointestinal tract structureGenderGoalsHealthHelicobacter pyloriHomeostasisHormonalHormonesHumanHuman MicrobiomeImmunityIncidenceIndigenousInflammationInheritedInsulinInsulin-Like Growth Factor IIntestinesLeptinLifeMetabolicModernizationMonozygotic TwinningMonozygotic twinsMothersMusNetherlandsNew York CityObesityPhenotypePhysiologyPlayPopulationRisk FactorsRoleSamplingSchool-Age PopulationSpecimenStomachStudy SubjectTestingTwin Multiple BirthUnited Statesbasecohortcytokinefasting plasma glucosegastrointestinalghrelinmicrobialmicrobiomenext generationobesity in childrenupper GI seriesyoung adult
项目摘要
DESCRIPTION (provided by applicant): The incidence of obesity has been rapidly increasing in the United States and other developed countries. Our hypothesis is that changes are occurring in the indigenous microbial populations that are of ancient origin, due to modernization including antibiotic exposure. Our hypothesis is that these changes in the composition of the microbiome are at least in part playing a role in the increasing incidence of obesity. More specifically, we also hypothesize that common antibiotic treatments are incidentally causing changes in the composition of metabolically active gastrointestinal bacterial populations, and that the effects may be sequential in which maternal changes are then inherited by the next generation. We will test this hypothesis by studying both the colonic microbiota, and Helicobacter pylori, the dominant gastric bacteria that interact with gastric epithelium, which produces hormones (leptin and ghrelin) that are involved in energy homeostasis. We propose 5 studies. Study A1 will be to assess the association of maternal H. pylori status on the development of childhood obesity in a presently enrolled cohort in The Netherlands. Study A2 will examine the relationship in children of H. pylori status and the physiology of gastric hormones, inflammation, and immunity. Study A3 will assess the changes in hormonal and metabolic phenotypes in young adults due to clinically indicated eradication of H. pylori. Study B1 will assess the effects on young mice of the continuous administration of low antibiotic doses in terms of metabolic and hormonal phenotypes. Study B2 will examine the development of the intestinal microbiota over the first year of life in singletons and twins, and will assess the effects of antibiotic perturbation on the developmental process. In total, these studies will examine the relationship changing gastric and colonic bacterial population composition with metabolic phenotypes, and provide opportunities for further exploration.
描述(由申请人提供):在美国和其他发达国家,肥胖症的发病率正在迅速上升。我们的假设是,由于包括抗生素暴露在内的现代化,古老起源的本地微生物种群正在发生变化。我们的假设是,这些微生物组组成的变化至少在一定程度上导致了肥胖发病率的增加。更具体地说,我们还假设常见的抗生素治疗偶然导致代谢活跃的胃肠道细菌群的组成发生变化,并且这种影响可能是连续的,母体的变化随后被下一代遗传。我们将通过研究结肠微生物群和幽门螺杆菌来验证这一假设,幽门螺杆菌是与胃上皮相互作用的主要胃细菌,胃上皮产生参与能量稳态的激素(瘦素和胃饥饿素)。我们提出了5项研究。研究A1将评估目前在荷兰登记的队列中母亲幽门螺杆菌状态与儿童肥胖发展的关系。研究A2将研究儿童幽门螺杆菌状态与胃激素、炎症和免疫生理的关系。研究A3将评估由于临床指示根除幽门螺杆菌而导致的年轻人激素和代谢表型的变化。研究B1将从代谢和激素表型方面评估低剂量持续给药对幼鼠的影响。研究B2将检查单胎和双胞胎出生后第一年肠道微生物群的发育,并将评估抗生素干扰对发育过程的影响。总之,这些研究将检验胃和结肠细菌种群组成变化与代谢表型的关系,并为进一步探索提供机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARTIN J BLASER其他文献
MARTIN J BLASER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARTIN J BLASER', 18)}}的其他基金
Cohort and biomarkers for COVID-19 severity, natural history, and reinfection
COVID-19 严重程度、自然病程和再感染的队列和生物标志物
- 批准号:
10689118 - 财政年份:2021
- 资助金额:
$ 121.64万 - 项目类别:
Cohort and biomarkers for COVID-19 severity, natural history, and reinfection
COVID-19 严重程度、自然病程和再感染的队列和生物标志物
- 批准号:
10490891 - 财政年份:2021
- 资助金额:
$ 121.64万 - 项目类别:
Cohort and biomarkers for COVID-19 severity, natural history, and reinfection
COVID-19 严重程度、自然病程和再感染的队列和生物标志物
- 批准号:
10375868 - 财政年份:2021
- 资助金额:
$ 121.64万 - 项目类别:
Microbial, immune, metabolic perturbations by antibiotics (MIME study)
抗生素对微生物、免疫、代谢的干扰(MIME 研究)
- 批准号:
10159190 - 财政年份:2019
- 资助金额:
$ 121.64万 - 项目类别:
Microbial, immune, metabolic perturbations by antibiotics (MIME study)
抗生素对微生物、免疫、代谢的干扰(MIME 研究)
- 批准号:
9923556 - 财政年份:2019
- 资助金额:
$ 121.64万 - 项目类别:
Microbial, immune, metabolic perturbations by antibiotics (MIME study)
抗生素对微生物、免疫、代谢的干扰(MIME 研究)
- 批准号:
9246429 - 财政年份:2016
- 资助金额:
$ 121.64万 - 项目类别:
Microbial, immune, metabolic perturbations by antibiotics (MIME study)
抗生素对微生物、免疫、代谢的干扰(MIME 研究)
- 批准号:
9037283 - 财政年份:2016
- 资助金额:
$ 121.64万 - 项目类别:
Mathematical Models of H. Pylori gastric colonization
幽门螺杆菌胃定植的数学模型
- 批准号:
8669633 - 财政年份:2013
- 资助金额:
$ 121.64万 - 项目类别:
Evaluation of the cutaneous microbiome in psoriasis
银屑病皮肤微生物群的评估
- 批准号:
8698894 - 财政年份:2013
- 资助金额:
$ 121.64万 - 项目类别:
相似海外基金
SBIR Phase II: Development of a urine dipstick test that can guide immediate and appropriate antibiotic therapy for treatment of complicated urinary tract infections
SBIR II 期:开发尿液试纸测试,可以指导复杂尿路感染的立即和适当的抗生素治疗
- 批准号:
2213034 - 财政年份:2023
- 资助金额:
$ 121.64万 - 项目类别:
Cooperative Agreement
Personalized Antibiotic Therapy in the Emergency Department: PANTHER Trial
急诊科的个性化抗生素治疗:PANTHER 试验
- 批准号:
10645528 - 财政年份:2023
- 资助金额:
$ 121.64万 - 项目类别:
Strategies for improving the efficacy of combinatorial antibiotic therapy in chronic infections
提高慢性感染联合抗生素治疗疗效的策略
- 批准号:
10736285 - 财政年份:2023
- 资助金额:
$ 121.64万 - 项目类别:
A Novel Bone Targeted Antibiotic Therapy for the Treatment of Infected Fractures
一种治疗感染性骨折的新型骨靶向抗生素疗法
- 批准号:
10603486 - 财政年份:2023
- 资助金额:
$ 121.64万 - 项目类别:
Severe Cutaneous Adverse Reactions Following Outpatient Antibiotic Therapy: A Population-based Study
门诊抗生素治疗后的严重皮肤不良反应:一项基于人群的研究
- 批准号:
449379 - 财政年份:2020
- 资助金额:
$ 121.64万 - 项目类别:
Studentship Programs
Sex-Specific Differences in End-of-Life Burdensome Interventions and Antibiotic Therapy in Nursing Home Residents With Advanced Dementia
患有晚期痴呆症的疗养院居民的临终干预和抗生素治疗的性别差异
- 批准号:
422034 - 财政年份:2020
- 资助金额:
$ 121.64万 - 项目类别:
Optimizing outpatient parenteral antibiotic therapy to support hospital-in-the-home program across the unique environmental conditions of Australia
优化门诊肠外抗生素治疗,以支持澳大利亚独特环境条件下的家庭医院计划
- 批准号:
nhmrc : 1197866 - 财政年份:2020
- 资助金额:
$ 121.64万 - 项目类别:
Investigator Grants
Resistance evolution in the presence of combination antibiotic therapy
联合抗生素治疗下耐药性的演变
- 批准号:
2241853 - 财政年份:2019
- 资助金额:
$ 121.64万 - 项目类别:
Studentship
Host-pathogen interactions in antibiotic therapy for listeriosis
李斯特菌病抗生素治疗中宿主与病原体的相互作用
- 批准号:
18K07106 - 财政年份:2018
- 资助金额:
$ 121.64万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Multipurpose targeted nano-antibiotic therapy to fight tough infection in bones
多用途靶向纳米抗生素疗法可对抗骨骼中的严重感染
- 批准号:
9788269 - 财政年份:2018
- 资助金额:
$ 121.64万 - 项目类别: